<DOC>
	<DOCNO>NCT00250068</DOCNO>
	<brief_summary>To determine overall response rate liposomal 9-Nitro-20 ( S ) -Camptothecin ( L9NC ) administer aerosolization patient non-small-cell lung cancer ( stage . To determine toxicity profile L9NC administer aerosolization 5 consecutive day per week X 8 week , every 10 week . To perform pharmacology study L9NC plasma , lung aerosolization . A specific protocol write part .</brief_summary>
	<brief_title>Study Aerosolized Liposomal 9-Nitro-20 ( S ) - Camptothecin ( L9NC )</brief_title>
	<detailed_description>This single-arm , non-randomized Phase II trial DLPC-9NC administer aerosol 5 consecutive day per week 8 week every 10 week . Dose : 0.4 mg/ml 9-NC aerosol reservoir 60 minute ( = daily dose 0.52 mg/m2/day ) per day X5 every week , X8 week , observe 2 week . One course = 10 week . Patients resectable lung cancer receive one course treatment operate two week complete 8-week course .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Rubitecan</mesh_term>
	<criteria>All patient , 18 year age old , resectable lung cancer ( stage ) stage 3b , 4 , recurrent , nonresectable , nonsmallcell lung carcinoma , fail standard chemotherapy radiotherapy disease refuse standard therapy eligible . Patients must life expectancy least 12 week . Patients must Zubrod performance status 02 . Patients must sign informed consent . Patients adequate bone marrow function define absolute peripheral granulocyte count &gt; 1,500 cells/mm3 platelet count &gt; 100,000/mm3 absence regular red blood cell transfusion requirement . Patients adequate hepatic function total bilirubin &lt; 2 mg/dl SGOT SGPT &lt; two time upper limit normal , adequate renal function define serum creatinine &lt; 1.5 x upper limit normal . Patients must know symptomatic respiratory disease cancer , must pulmonary function test equal &gt; 50 % FEV1 , &gt; 50 % FEV1/FVC , &gt; 50 % TLC , &gt; 50 % DLCO predict value . Patients symptomatic brain metastasis exclude study . Pregnant woman nurse mother eligible trial . Patients child bear potential must use adequate contraception . Patients may receive concurrent chemotherapy radiation therapy trial . Patients severe medical problem uncontrolled diabetes mellitus cardiovascular disease active infection eligible trial . Any criterion borderline may lead ineligibility review PI , may override eligibility criterion , receive sponsor agreement , entry study deem potentially benefit patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Phase II</keyword>
	<keyword>Aerosol Delivery</keyword>
	<keyword>NSCLC</keyword>
	<keyword>9-Nitrocamptothecin</keyword>
</DOC>